Azuma, Yoshinori
291  results:
Search for persons X
?
3

Possible Advantage of Glucagon-Like Peptide 1 Receptor Agon..:

Sato, Tetsuhiko ; Azuma, Yoshinori ; Ozone, Chikafumi...
The Journal of Clinical Endocrinology & Metabolism.  108 (2023)  10 - p. 2597-2603 , 2023
 
?
5

ODP083 Burosumab Treatment for Fibrous dysplasia/McCune-Alb..:

Sato, Tetsuhiko ; Azuma, Yoshinori ; Tauchi, Ryoji..
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A160-A160 , 2022
 
?
6

A Possible Advantage of Glucagon-Like Peptide 1 Receptor Ag..:

Sato, Tetsuhiko ; Ohara, Emi ; Ozone, Chikafumi...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A405-A406 , 2021
 
?
11

Serum squamous cell carcinoma antigen (SCCA)-2 correlates w..:

Takeuchi, Satoshi ; Furusyo, Norihiro ; Ono, Junya...
Journal of Dermatological Science.  95 (2019)  2 - p. 70-75 , 2019
 
?
13

Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Eme..:

Izuhara, Kenji ; Yamaguchi, Yukie ; Ohta, Shoichiro...
International Journal of Molecular Sciences.  19 (2018)  4 - p. 1102 , 2018
 
?
14

Serum squamous cell carcinoma antigen-2 is a highly sensiti..:

Kawano, Toshiaki ; Nagao, Mizuho ; Fujisawa, Takao...
Journal of Allergy and Clinical Immunology.  141 (2018)  2 - p. AB133 , 2018
 
?
 
1-15